Kura Oncology (KURA) Enterprise Value Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Kura Oncology 801.92 Mn 801.92 Mn 18.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -12.69%
Dec 31, 2025 -15.06%
Sep 30, 2025 -8.72%
Jun 30, 2025 -11.89%
Mar 31, 2025 -11.09%
Dec 31, 2024 -11.98%
Sep 30, 2024 5.73%
Jun 30, 2024 4.68%
Mar 31, 2024 4.43%
Dec 31, 2023 12.52%
Sep 30, 2023 -11.62%
Jun 30, 2023 -12.07%
Mar 31, 2023 -23.22%
Dec 31, 2022 -22.74%
Sep 30, 2022 -19.59%
Jun 30, 2022 -19.87%
Mar 31, 2022 -42.61%
Dec 31, 2021 -42.50%
Sep 30, 2021 -42.60%
Jun 30, 2021 -65.19%
Mar 31, 2021 -63.49%
Dec 31, 2020 -89.45%
Sep 30, 2020 -47.79%
Jun 30, 2020 -85.32%
Mar 31, 2020 -54.21%
Dec 31, 2019 -51.75%
Sep 30, 2019 -49.69%
Jun 30, 2019 -48.34%
Mar 31, 2019 -30.63%
Dec 31, 2018 -27.80%
Sep 30, 2018 -65.65%
Jun 30, 2018 -39.94%
Mar 31, 2018 -37.15%
Dec 31, 2017 -335.98%
Sep 30, 2017 -971.25%
Jun 30, 2017 -2,112.22%
Mar 31, 2017 -2,024.60%
Dec 31, 2016 -2,077.26%
Sep 30, 2016 -1,817.30%
Jun 30, 2016 -1,523.83%
Mar 31, 2016 -2,847.05%
Dec 31, 2015 -2,513.75%
Sep 30, 2015 -1,847.05%
Jun 30, 2015 -1,592.09%
Mar 31, 2015 -1,211.59%
Dec 31, 2014 -543.41%
Sep 30, 2014 -137.06%
Jun 30, 2014 19.00%
Mar 31, 2014 -13.49%
Dec 31, 2013 37.50%
Sep 30, 2013 -67.43%